- Home
- SSB vs BBIO Comparison
SSB vs BBIO Comparison
Compare SSB & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSB
- BBIO
- Stock Information
- Founded
- SSB 1933
- BBIO 2015
- Country
- SSB United States
- BBIO United States
- Employees
- SSB N/A
- BBIO N/A
- Industry
- SSB Major Banks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SSB Finance
- BBIO Health Care
- Exchange
- SSB Nasdaq
- BBIO Nasdaq
- Market Cap
- SSB 10.0B
- BBIO 9.4B
- IPO Year
- SSB 1997
- BBIO 2019
- Fundamental
- Price
- SSB $103.12
- BBIO $53.38
- Analyst Decision
- SSB Strong Buy
- BBIO Strong Buy
- Analyst Count
- SSB 11
- BBIO 16
- Target Price
- SSB $116.80
- BBIO $63.81
- AVG Volume (30 Days)
- SSB 741.0K
- BBIO 2.4M
- Earning Date
- SSB 10-22-2025
- BBIO 08-05-2025
- Dividend Yield
- SSB 2.33%
- BBIO N/A
- EPS Growth
- SSB 6.15
- BBIO N/A
- EPS
- SSB 6.62
- BBIO N/A
- Revenue
- SSB $2,064,671,000.00
- BBIO $235,812,000.00
- Revenue This Year
- SSB $55.55
- BBIO $115.49
- Revenue Next Year
- SSB $5.14
- BBIO $64.61
- P/E Ratio
- SSB $15.55
- BBIO N/A
- Revenue Growth
- SSB 26.69
- BBIO 7.62
- 52 Week Low
- SSB $77.74
- BBIO $21.72
- 52 Week High
- SSB $114.27
- BBIO $53.97
- Technical
- Relative Strength Index (RSI)
- SSB 65.42
- BBIO 63.37
- Support Level
- SSB $100.22
- BBIO $49.75
- Resistance Level
- SSB $102.61
- BBIO $52.85
- Average True Range (ATR)
- SSB 2.04
- BBIO 2.12
- MACD
- SSB 0.46
- BBIO 0.18
- Stochastic Oscillator
- SSB 81.18
- BBIO 91.76
About SSB SouthState Corporation
SouthState Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary, South State Bank. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.